Evidence map›Paper›PMID 29276617›Full record

ReviewGlobal health, epidemiology and genomics2017

Antimicrobial resistance in human populations: challenges and opportunities.

S Allcock, E H Young, M Holmes, D Gurdasani, G Dougan, M S Sandhu, L Solomon, M E Török

Erratum issuedAbstract readReview
In one paragraph

Review in Global health, epidemiology and genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Metabolism-Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Community gut colonization byFrontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Global trends in antibiotic consumption during 2016-2023 and future projections through 2030.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

S AllcockDepartment of Medicine, University of Cambridge, Cambridge, UK.
E H YoungDepartment of Medicine, University of Cambridge, Cambridge, UK.
M HolmesDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
D GurdasaniDepartment of Medicine, University of Cambridge, Cambridge, UK.
G DouganWellcome Trust Sanger Institute, Genome Campus, Hinxton, UK.
M S SandhuDepartment of Medicine, University of Cambridge, Cambridge, UK.
L SolomonJeremy Coller Foundation, London, UK.
M E TörökDepartment of Medicine, University of Cambridge, Cambridge, UK.

Funding

Medical Research Council G1001787Medical Research Council MR/K013491/1Medical Research Council MR/N002660/1Medical Research Council MR/N029399/1Medical Research Council MR/P007201/1Wellcome Trust
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global public health threat. Emergence of AMR occurs naturally, but can also be selected for by antimicrobial exposure in clinical and veterinary medicine. Despite growing worldwide attention to AMR, there are substantial limitations in our understanding of the burden, distribution and determinants of AMR at the population level. We highlight the importance of population-based approaches to assess the association between antimicrobial use and AMR in humans and animals. Such approaches are needed to improve our understanding of the development and spread of AMR in order to inform strategies for the prevention, detection and management of AMR, and to support the sustainable use of antimicrobials in healthcare.

Indexed as

Animalantimicrobialhumanmultidrug-resistantresistance

Identifiers

PMID29276617
PMCPMC5732576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.